Warren Buffett Is No Longer Berkshire's Chairman. Here’s Why I'm Buying the Stock Anyway.

Warren Buffett stepped down as Berkshire Hathaway executive chairman effective immediately, becoming chairman emeritus; Howard Buffett succeeds him as chairman while Greg Abel remains CEO and capital allocator. The article argues the transition was largely priced in, noting Berkshire shares barely moved and had already fallen below their pre-May 2025 shareholder-meeting high. Abel ended 14 consecutive quarters of net equity selling in Q2, increased buybacks to their highest level in five years, and completed a substantial acquisition of a beaten-down homebuilder, supporting confidence in post-Buffett capital deployment.

Analysis

The relevant valuation question is no longer succession but whether Greg Abel can convert Berkshire's liquidity into returns above the opportunity cost of holding cash. A sustained acceleration in repurchases would support per-share intrinsic value only if conducted below conservatively marked book/intrinsic value; a large acquisition, by contrast, creates an immediate execution and multiple-risk test because Berkshire's scale limits the universe of accretive targets. The market should assign a modest governance discount during the first 1-3 quarters of fully independent capital allocation, particularly if equity purchases become more cyclical or concentrated than under Buffett.

The second-order beneficiary could be the U.S. housing complex if Berkshire's new homebuilding exposure signals willingness to add capital near a housing-cycle trough: DHI, PHM, LEN and XHB would benefit from renewed investor focus on land-bank optionality and eventual mortgage-rate normalization. But Berkshire is a poor pure-play way to express that view; its insurance float, BNSF, utilities and public-equity portfolio can swamp any acquired-builder contribution. Contrarian view: consensus may be too focused on a symbolic leadership event and too optimistic about capital deployment—deploying cash is not itself value creation, and the stock's premium can compress if acquisition returns lag repurchases or Treasury yields remain attractive.

Near term, expect limited fundamental repricing absent disclosed buyback volume, a material acquisition price, or changes in operating-insurance earnings. Over 6-18 months, the key catalyst is evidence that post-succession underwriting discipline and decentralized operating margins remain intact while capital deployment improves per-share growth. The thesis is falsified by a sustained reduction in repurchases despite a discounted share price, a large deal that dilutes return on equity, adverse reserve development, or a guidance/filing signal that cash generation is weakening.

Key Decisions for Investors

• Maintain or initiate a modest long BRK.B rather than BRK.A for liquidity, using a 3-6 month horizon; add only on succession-driven weakness of roughly 8-10% without deterioration in insurance operating earnings or repurchase activity. Risk/reward is asymmetric only if the shares trade at a clear discount to estimated intrinsic value; do not chase a governance-relief rally.
• Set a filing-driven alert for quarterly repurchases, equity purchases and acquisition consideration. Increase BRK exposure only if per-share book/intrinsic-value accretion is supported by buybacks or clearly disciplined deal terms; treat a large, high-multiple acquisition as a de-risking trigger rather than a catalyst.
• For a housing-cycle expression, prefer a separate 6-12 month basket long XHB or selective longs DHI/PHM versus BRK.B. This isolates the potential homebuilder rerating while avoiding Berkshire's conglomerate and succession valuation risk; exit if mortgage rates rise materially or builder orders/cancellations weaken.
• Avoid using NFLX or NVDA as read-through trades. They are incidental references rather than demonstrated beneficiaries of Berkshire's capital-allocation transition, and any perceived linkage is unlikely to produce a durable earnings or valuation catalyst.